Stay updated with breaking news from Michael Grunkin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
COPENHAGEN, Denmark & BOSTON, August 15, 2023--Visiopharm and Boston Cell Standards today announced a partnership to develop a joint technology solution that enables labs to meet key provisions of regulatory changes proposed in a groundbreaking editorial recently published in Archives of Pathology & Laboratory Medicine.
SEOUL, South Korea (PRWEB) November 15, 2022 -- Deep Bio, a leading AI biotech dedicated to cancer diagnosis, and Visiopharm, a world leader in AI-powered
Partnership to improve clinical decision making for breast and colon cancer care Proscia, a leader in digital and computational pathology solutions, and Visiopharm, a world leader in AI-driven precision
Visiopharm, a leader in AI-based digital pathology, has begun its partnership with the Region of Southern Denmark, to supply the network of four hospitals with